Rituximab in primary conjunctiva lymphoma

Leukemia Research

Volumn 29, Issue 1, 2005, Pages 107-108

  Zinzani, Pier Luigi ^a   Alinari, Lapo ^a   Stefoni, Vittorio ^a   Loffredo, Antonio ^b   Pichierri, Patrizia ^b   Polito, Ennio ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Conjunctiva lymphoma; Rituximab; Treatment

Indexed keywords

RITUXIMAB;

ADULT; ARTICLE; CASE REPORT; CONJUNCTIVA DISEASE; CONJUNCTIVA LYMPHOMA; DOSE RESPONSE; EXPERIENCE; EYE TOXICITY; FEMALE; HUMAN; LYMPHOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; ANTINEOPLASTIC AGENTS; CONJUNCTIVAL NEOPLASMS; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN;

EID: 8444227064     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2004.05.011     Document Type: Article

References (4)

1. Harris N L., Jaffe E S., Stein H., et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 84:1994;1361-1392
2. Seregard S., Boniuk M. Ocular adnexal lymphomas: five case presentations and a review of the literature. Surv Ophthalmol. 47:2002;470-490
3. Sasai K., Yamabe H., Dodo Y., et al. Non-Hodgkin's lymphoma of the ocular adnexa. Acta Oncol. 40:2001;485-490
4. Zinzani P L., Magagnoli M., Galieni P., et al. Nongastrointestinal low-grade mucosa associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol. 17:1999;1254-1258